Post-effective amendment to a registration statement that is not immediately effective upon filing

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment
Convertible Preferred Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Notes Receivable
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Convertible Preferred Stock
Series E Preferred Stock
Common Stock
Series E Preferred Stock
Additional Paid-In Capital
Series E Preferred Stock
Series E1 Preferred Stock
Common Stock
Series E1 Preferred Stock
Additional Paid-In Capital
Series E1 Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Notes Receivable
Total
BALANCE at Dec. 31, 2018 $ (276,889)                   $ 276,889                        
BALANCE (in shares) at Dec. 31, 2018 (84,092,669)                   84,092,669                        
BALANCE at Dec. 31, 2019 $ (436,533)                   $ 436,533                        
BALANCE (in shares) at Dec. 31, 2019 (100,038,109)                   100,038,109                        
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]                                              
Issuance of Preferred Stock (in shares)                       16,426,267     3,046,623                
Issuance of Preferred Stock                       $ 2 $ 134,665 $ 134,667   $ 24,977 $ 24,977            
BALANCE at Dec. 31, 2018   $ 11 $ 276,878 $ 276,889 $ 13 $ 283,318 $ (190,666) $ (96) $ (249) $ 92,320               $ 2 $ 6,440 $ (190,666) $ (96) $ (249) $ (184,569)
BALANCE (in shares) at Dec. 31, 2018   106,977,440     126,329,695                         19,352,255          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Exercise of Common Stock options                                     708       708
Exercise of Common Stock options (in shares)                                   1,217,255          
Vesting of restricted Common Stock                                   $ 1 7       8
Vesting of restricted Common Stock (in shares)                                   6,904,182          
Issuance of Common Stock for acquisitions                                     3,563       3,563
Issuance of Common Stock for acquisitions (in shares)                                   1,066,373          
Stock-based compensation expense                                     5,215       5,215
Common Stock warrants issued                                     1,038       1,038
Net loss                                       (103,596)     (103,596)
Other comprehensive income (loss)                                         171   171
BALANCE at Dec. 31, 2019   $ 13 436,520 436,533 $ 16 453,242 (294,262) 75   159,071               $ 3 16,722 (294,262) 75   (277,462)
BALANCE (in shares) at Dec. 31, 2019   128,100,821     154,913,934                         26,813,113          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Repayment of notes receivable                                     (249)     $ 249  
Repayment of notes receivable (in shares)                                   (76,461)          
Exercise of Common Stock options                                     132       132
Exercise of Common Stock options (in shares)                                   286,636          
Vesting of restricted Common Stock                                     2       2
Vesting of restricted Common Stock (in shares)                                   1,750,555          
Stock-based compensation expense                                     1,259       1,259
Common Stock warrants issued                                     124       124
Net loss                                       (21,804)     (21,804)
Other comprehensive income (loss)                                         (159)   (159)
BALANCE at Mar. 31, 2020                                   $ 16 454,759 (316,066) (84)   $ 138,625
BALANCE (in shares) at Mar. 31, 2020                                   156,951,125          
BALANCE at Dec. 31, 2019 $ (436,533)                   $ 436,533                        
BALANCE (in shares) at Dec. 31, 2019 (100,038,109)                   100,038,109                        
BALANCE (in shares) at Dec. 31, 2020                                             100,038,109
BALANCE at Dec. 31, 2019   $ 13 $ 436,520 $ 436,533 $ 16 $ 453,242 $ (294,262) $ 75   $ 159,071               $ 3 16,722 (294,262) 75   $ (277,462)
BALANCE (in shares) at Dec. 31, 2019   128,100,821     154,913,934                         26,813,113          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Exercise of Common Stock options                                     325       325
Exercise of Common Stock options (in shares)                                   521,925          
Vesting of restricted Common Stock                                   $ 1 6       7
Vesting of restricted Common Stock (in shares)                                   5,307,357          
Repurchase of shares for employee tax withholdings (in shares)                                   (9,308)          
Issuance of Common Stock for acquisitions                                     500       500
Issuance of Common Stock for acquisitions (in shares)                                   61,060          
Stock-based compensation expense                                     8,006       8,006
Common Stock warrants issued                                     1,915       1,915
Common Stock warrants issued (in shares)                                   692,366          
Net loss                                       (34,015)     (34,015)
Other comprehensive income (loss)                                         (84)   (84)
BALANCE at Dec. 31, 2020                                   $ 23 844,188 (328,277) (9)   515,925
BALANCE (in shares) at Dec. 31, 2020                                   224,626,597          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Reverse recapitalization, net of transaction costs                                   $ 6 380,295       380,301
Reverse recapitalization, net of transaction costs (in shares)                                   63,139,263          
Exercise of Common Stock options                                     180       180
Exercise of Common Stock options (in shares)                                   163,228          
Vesting of restricted Common Stock (in shares)                                   56,015          
Vesting of restricted stock units (in shares)                                   15,265          
Repurchase of shares for employee tax withholdings                                     (54)       (54)
Repurchase of shares for employee tax withholdings (in shares)                                   (2,241)          
Issuance of Common Stock for acquisitions                                     159,847       159,847
Issuance of Common Stock for acquisitions (in shares)                                   5,036,142          
Stock-based compensation expense                                     2,217       2,217
Vesting of Trine Founder shares (in shares)                                   1,850,938          
Exercise of warrants                                   $ 2 320,567       320,569
Exercise of warrants (in shares)                                   20,690,975          
Net loss                                       (59,108)     (59,108)
Other comprehensive income (loss)                                         (12)   (12)
BALANCE at Mar. 31, 2021                                   $ 25 $ 1,326,945 $ (387,385) $ (21)   $ 939,564
BALANCE (in shares) at Mar. 31, 2021                                   252,436,919